Login Get in touch
Food Safety Incidents

Unapproved Drugs has been detected in Mavix .

January 30 2025

Explore Regulations & Risks

On January 7, 2025, the U.S. Food and Drug Administration (FDA) reported the detection of unapproved drugs in the product Mavix. This incident has been classified under the category of "Other incident" and falls within the Hazard Category...

Articles in this database are automatically generated by our AI system based on data from the Digicomply APP. While we strive for accuracy, the articles may not contain complete or verified information and are intended for informational purposes only. For accurate and reliable information, we recommend using SGS Digicomply or consulting verified sources and experts. All content is copyrighted; please credit SGS Digicomply (digicomply.com) when sharing.

On January 7, 2025, the U.S. Food and Drug Administration (FDA) reported the detection of unapproved drugs in the product Mavix. This incident has been classified under the category of "Other incident" and falls within the Hazard Category of "Contaminants." The issue originates from the United States of America and raises concerns regarding the safety and compliance of the product.

The presence of unapproved drugs in Mavix could pose potential risks to consumers, leading to increased scrutiny from regulatory bodies. The FDA is responsible for ensuring that products available to the public meet safety standards, and the identification of such contaminants may result in further investigations and actions to protect public health.

As this incident unfolds, it is essential for stakeholders in the pharmaceutical industry, as well as consumers, to remain informed about the developments regarding Mavix. The FDA's involvement highlights the importance of regulatory oversight in maintaining the integrity of products available in the marketplace.

For further updates or information on this incident, it is advisable to consult the official communications from the U.S. Food and Drug Administration.


  • Incident: Unapproved Drugs has been detected in Mavix .
  • Date: 2025-01-07
  • Product: Mavix
  • Market: Available to SGS Digicomply users only. Explore the platform (for enterprises, no individual plans)
  • Origin of issue: United States of America
  • Hazard: Available to SGS Digicomply users only. Explore the platform (for enterprises, no individual plans)
  • Incident Category: Other incident
  • Hazard Category: Contaminants
  • Source: U.S. Food and Drug Administration

For more detailed information about this and other similar incidents, with access to filtering options, historical data, and trend analysis, try the SGS Digicomply Food Safety Software. Explore SGS Digicomply Food Safety Intelligence Hub demos here. (for enterprises only, no individual plans)

Tags: United States of America, U.S. Food and Drug Administration, Other incident, Contaminants, January 2025